Muhammet Ali KAPLAN, Eşref ARAÇ, Idris ORUC, Zeynep ORUC

A case of fascioliasis mimicking malignancy

Fascioliasis is a zoonotic infection usually observed in developing countries and is endemic in Southeast Anatolia,Turkey.Sometimes,its clinical symptoms may mimic and resemble those of other diseases,such as malignancy or stone. Fascioliasis,initially considered as malignancy, can lead to unnecessary invasive procedures. A 69-year-old man presented with hepatic masses.Positron emission tomography (PET/CT), upper gastrointestinal endoscopy and colonoscopy performed to detect the primarytumour showed no lesion, except in the liver. The patient had eosinophilia and a history of raising livestock in an endemic area.The result of the indirect hemagglutination test for Fasciolia hepatica was 1/320. Serologic evaluation and dynamic computedtomography confirmed the diagnosis. Occassionally, it may be difficult to differentiate fascioliasis from malignancy. Fascioliasisshould be considered in the differential diagnosis of patients with suspicious masses in the liver, especially in those living in endemicareas,prior to conducting invasive procedures.

PDF

___

1. Mas-Coma S.Epidemiology of fascioliasis in human areas. J Helminthol 2005;79,207-216
2. Ozturhan H, Emekdaş G, Sezgin O, et al. SSeroepidemiology of Fasciola Hepatica in Mersin province and surrounding towns and the role of family history of the Fascioliasis in the transmission of the parasite. Turk J Gastroenterol 2009;20:198-203
3. Yılmaz B, Köklü S, Gedikoğlu G. Hepatic mass caused by Fascioa hepatica:a tricky differential diagnosis. Am J Trop Med Hyg 2013;89:1212-3.
4. Bektaş M, Dökmeci A, Çınar K, et al. Endoscopic management of biliary parasitic diseases. Dig Dis Sci 2010;55:1472-8.
5. Espinoza JR, Maco V, Marcos L, et al. Evaluation of Fas2- ELISA for the serological detection of Fasciola hepatica infection in humans. Am J Trop Med Hyg 2007;76:977-82.
6. Ezzat RF, Karboli TA, Kasnazani KA, et al. Endoscopic management of biliary fascioliasis: a case report. AM J Med Case Reports 2010;4:83.
7. Behar JM, Winston JS, Borgstein R. Hepatic fascioliasis at a London hospital the importance of recognising typical radiological features to avoid a delay in diagnosis. Br J Radiol 2009;82:189-93.
8. Millan JC, Mull R, Freise S, et al. Triclabendazole Study Group.The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection. Am J Trop Med Hyg 2000;63:264-9.
9. Pilsczek FH. Helminthic infections mimicking malignancy:a review of published case reports. J Infect Dev Ctries 2010;4:425-9.
10. Dias LM, Silva R, Viana HL, et al. Biliary fascioliasis: diagnosis, treatment and follow-up by ERCP. Gastrointest Endosc 1996;43:616-9.
11. Şenateş E, Doğan A, Şenates BE, et al. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma. Infez Med. 2014;22:313-6
12. Han JK, Choi BI, Cho JM, et al. Radiological findings of human fascioliasis. Abdom Imaging 1993;18:261-4.
13. Hillyer GV, Soler de Galanes M, Rodriquez-perez J, et al. Use of the falcon assay screening test enzyme linked immunoserbent assay (FAST-ELISA) and the enzyme linked immunoelectrotransfer blot (ZITB) to determine the prevalance of human fascioliasis in the Bolivian Altiplano. Am J Trop Med Hyg 1992;46:603-9
14. Keiser J, Engels D, Buscher G, et al.Trilabendazole for the treatment of fascioliasis and paragonimiasis. Expert Opin Investig Drugs 2005;14:1513-26.
15. Chitsulo, Montresor and Savioli. New opportunities for the control of fascioliasis. Bulletin of the World Health Organization.16 May 2001